Inclisiran: a new generation of lipid-lowering siRNA therapeutic.
Zhang Y, Chen H, Hong L, Wang H, Li B, Zhang M, Li J, Yang L, Liu F.
Zhang Y, et al. Among authors: li j, li b.
Front Pharmacol. 2023 Oct 13;14:1260921. doi: 10.3389/fphar.2023.1260921. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37900173
Free PMC article.
Review.